+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Entreal), Product (Powder, Pills), Application, Module, Sales Channel, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2024
  • Region: Asia Pacific
  • Grand View Research
  • ID: 6024589
Description Jump to:
The Asia Pacific medical foods market size is anticipated to reach USD 9.94 billion by 2030. The market is expected to grow at a CAGR of 6.27% from 2025 to 2030. The rapid rate of urbanization and increasing geriatric population has created a need for managing diseases that affect the older population as well as those with sedentary lifestyles.

Based on route of administration, the oral segment accounted for the largest revenue share of 73.57% in 2024. The majority of the medical foods available are for oral consumption. The ease of administration and rising consumer demand contribute to the largest market share of this segment. The enteral route of administration registered the fastest CAGR of 6.6% from 2025 to 2030. The growing population suffering from diseases that render them unable to consume food orally has led to this growth. Enteral feeding has been proving effective in several cases, with better absorption of nutrients and lesser contamination rates.

In the product type segment, powder formulations recorded the largest revenue share of the market in 2024. The majority of product offerings currently available in the market are in powder formulations. Easy storage and longer shelf life of these products are one of the key factors leading to the wider adoption of this product type. The liquid formulations segment is expected to register the fastest growth over the forecast period, as the key players are diversifying their product portfolios to cater to larger populations. This segment is expected to have maximum growth potential in the medical foods industry.

In 2024, chemotherapy-induced diarrhea accounted for the largest revenue share in the application segment, due to the high burden of cancer and the need for proper management of the disease. Nutritional supplementation through medical foods has become necessary in the management of cancer, thus driving the growth in demand for medical foods in this segment. The diabetic neuropathy segment is expected to register the fastest CAGR during the forecast period. This is due to the rise in prevalence of the disease in the rapidly developing nations in the Asia Pacific (APAC) and the increasing demand for nutrient-rich foods for the management of this condition.

In 2024, institutional sales accounted for the largest revenue share in the sales channel segment. APAC is still an untapped space with a huge potential for growth, the primary channel for the purchase of medical foods is through doctors in clinics and health centers that rely on medical representatives which are hired by market players for distribution of the product. The online platform is expected to witness the fastest CAGR in the forthcoming years, due to the rising awareness about the benefits of medical foods in disease management. Major market players are increasing their reach by diversifying their distribution channels and collaborating to sell their medical foods products online, directly to consumers.

The COVID-19 pandemic adversely affected the growth of the APAC medical foods market, because the majority of the medical food products in the market are being imported from other countries, with the trade restrictions in place the supply chain was severely affected. The market is expected to pick up, as the demand for these products has been increasing due to the deteriorating health of people and the growing geriatric population.

Asia Pacific Medical Foods Market Report Highlights

  • The oral route of administration accounted for the largest revenue share of 73.57% in 2024 as a result of high product type availability and ease of administration.
  • The powder formulations in product type had the largest revenue share of 35.88% due to ease of use and maximum product availability.
  • Diabetic neuropathy is expected to register the fastest growth in the application segment during the forecast period of 2025 - 2030. High disease burden and the need for proper management of the disease are key factors for growth.
  • Institutional sales is anticipated to grow significantly over the forecast period. The segment's growth is driven by increasing recommendations from doctors to use medical foods. Institutions that purchase medical foods include hospitals, long-term care centers, hospices, clinics, and disability facilities

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Asia-Pacific Medical Foods market include:

  • Mead Johnson & Company, LLC
  • SHS International ltd
  • Synutra International ltd
  • Milupa Gmbh
  • Danone
  • Nestlé
  • Abbott
  • Fresenius Kabi AG


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Route of Administration
1.1.2. Product
1.1.3. Application
1.1.4. Module
1.1.5. Sales Channel
1.1.6. Country scope
1.1.7. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Route of administration outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Module outlook
2.2.5. Sales channel outlook
2.2.6. Country outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Medical Foods Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Asia Pacific Medical Foods Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact
Chapter 4. Asia Pacific Medical Foods Market: Route of Administration Estimates & Trend Analysis
4.1. Route of Administration Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Asia Pacific Medical Foods Market by Route of Administration Outlook
4.4. Oral
4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.5. Enteral
4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 5. Asia Pacific Medical Foods Market: Product Estimates & Trend Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Asia Pacific Medical Foods Market by Product Outlook
5.4. Pills
5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.5. Powder
5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.6. Liquid
5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.7. Others (semisolid, semiliquid)
5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Asia Pacific Medical Foods Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Asia Pacific Medical Foods Market by Application Outlook
6.4. Chronic Kidney Disease
6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.5. Minimal Hepatic Encephalopathy
6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.6. Chemotherapy Induced Diarrhea
6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.7. Pathogen Related Infections
6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.8. Diabetic Neuropathy
6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.9. ADHD
6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.10. Depression
6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.11. Alzheimer's Disease
6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.12. Nutritional Deficiency
6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13. Orphan Diseases
6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.2. Tyrosinemia
6.13.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.3. Eosinophilic Esophagitis
6.13.3.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.4. Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES))
6.13.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.5. Phenylketonuria (PKU)
6.13.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.6. Maple syrup urine disease (Maple syrup urine disease (MSUD))
6.13.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.7. Homocystinuria
6.13.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13.8. Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
6.13.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.14. Wound Healing
6.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.15. Chronic Diarrhea
6.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.16. Constipation Relief
6.16.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.17. Protein Booster
6.17.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.18. Dysphagia
6.18.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.19. Pain Management
6.19.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.20. Parkinson's Disease
6.20.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.21. Epilepsy
6.21.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.22. Other Cancer related treatments
6.22.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.23. Severe Protein Allergy
6.23.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.24. Cancer
6.24.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.25. Cachexia
6.25.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.26. Other (debilitating conditions, COPD, etc.)
6.26.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 7. Asia Pacific Medical Foods Market: Modules Estimates & Trend Analysis
7.1. Modules Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Asia Pacific Medical Foods Market by Modules Outlook
7.4. Amino Acid Module
7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.5. Protein Module
7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.6. Vitamin & Mineral Modules
7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.7. Fatty Acid based Modules
7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.8. Carbohydrate Modules
7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.9. Fiber Modules
7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.10. Ketogenic Modules
7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.11. Peptide based Modules
7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.12. Hypoallergic Modules
7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.13. Others (Electrolyte Module, etc.)
7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 8. Asia Pacific Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1. Sales Channel Market Share, 2024 & 2030
8.2. Segment Dashboard
8.3. Asia Pacific Medical Foods Market by Sales Channel Outlook
8.4. DTC Sales Channel
8.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
8.4.2. Online Sales
8.4.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
8.4.3. Retail Sales
8.4.3.1. Market estimates and forecast 2018 - 2030 (USD Million)
8.5. Institutional Sales
8.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
8.5.2. Hospitals
8.5.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
8.5.3. Others (Long-term Care Facilities, etc.)
8.5.3.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 9. Asia Pacific Medical Foods Market: Country Estimates & Trend Analysis, By Route of Administration, By Product, By Application, By Module, By Sales Channel
9.1. Country Market Share Analysis, 2024 & 2030
9.2. Country Market Dashboard
9.3. Country Market Snapshot
9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
9.5.3. Australia
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
9.5.4. India
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
9.5.7. Vietnam
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Vietnam market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Innovators
10.4. Vendor Landscape
10.4.1. List of key distributors and channel partners
10.4.2. Key customers
10.4.3. Key company market share analysis, 2024
10.4.4. Mead Johnson & Company, LLC
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Technology Type benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Nestlé
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Technology Type benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Abbott
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Technology Type benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Danone
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Technology Type benchmarking
10.4.7.4. Strategic initiatives
10.4.8. SHS International ltd
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Technology Type benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Fresenius Kabi AG
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Technology Type benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Synutra International ltd
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Technology Type benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Milupa Gmbh
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Technology Type benchmarking
10.4.11.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Asia Pacific medical foods market, by region, 2018 - 2030 (USD Million)
Table 3 Asia Pacific medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 4 Asia Pacific medical foods market, by product, 2018 - 2030 (USD Million)
Table 5 Asia Pacific medical foods market, by application, 2018 - 2030 (USD Million)
Table 6 Asia Pacific medical foods market, by modules, 2018 - 2030 (USD Million)
Table 7 Asia Pacific medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 8 Japan medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 9 Japan medical foods market, by product, 2018 - 2030 (USD Million)
Table 10 Japan medical foods market, by application, 2018 - 2030 (USD Million)
Table 11 Japan medical foods market, by modules, 2018 - 2030 (USD Million)
Table 12 Japan medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 13 China medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 14 China medical foods market, by product, 2018 - 2030 (USD Million)
Table 15 China medical foods market, by application, 2018 - 2030 (USD Million)
Table 16 China medical foods market, by modules, 2018 - 2030 (USD Million)
Table 17 China medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 18 Australia medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 19 Australia medical foods market, by product, 2018 - 2030 (USD Million)
Table 20 Australia medical foods market, by application, 2018 - 2030 (USD Million)
Table 21 Australia medical foods market, by modules, 2018 - 2030 (USD Million)
Table 22 Australia medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 23 India medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 24 India medical foods market, by product, 2018 - 2030 (USD Million)
Table 25 India medical foods market, by application, 2018 - 2030 (USD Million)
Table 26 India medical foods market, by modules, 2018 - 2030 (USD Million)
Table 27 India medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 28 South Korea medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 29 South Korea medical foods market, by product, 2018 - 2030 (USD Million)
Table 30 South Korea medical foods market, by application, 2018 - 2030 (USD Million)
Table 31 South Korea medical foods market, by modules, 2018 - 2030 (USD Million)
Table 32 South Korea medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 33 Thailand medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 34 Thailand medical foods market, by product, 2018 - 2030 (USD Million)
Table 35 Thailand medical foods market, by application, 2018 - 2030 (USD Million)
Table 36 Thailand medical foods market, by modules, 2018 - 2030 (USD Million)
Table 37 Thailand medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 38 Vietnam medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 39 Vietnam medical foods market, by product, 2018 - 2030 (USD Million)
Table 40 Vietnam medical foods market, by application, 2018 - 2030 (USD Million)
Table 41 Vietnam medical foods market, by modules, 2018 - 2030 (USD Million)
Table 42 Vietnam medical foods market, by sales channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Asia Pacific medical foods market: market outlook
Fig. 9 Computer aided detection competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Asia Pacific medical foods market driver impact
Fig. 15 Asia Pacific medical foods market restraint impact
Fig. 16 Asia Pacific medical foods market strategic initiatives analysis
Fig. 17 Asia Pacific medical foods market: Route of administration movement analysis
Fig. 18 Asia Pacific medical foods market: Route of administration outlook and key takeaways
Fig. 19 Oral market estimates and forecast, 2018 - 2030
Fig. 20 Enteral market estimates and forecast, 2018 - 2030
Fig. 21 Asia Pacific medical foods market: Product movement analysis
Fig. 22 Asia Pacific medical foods market: Product outlook and key takeaways
Fig. 23 Pills market estimates and forecast, 2018 - 2030
Fig. 24 Powder market estimates and forecast, 2018 - 2030
Fig. 25 Liquid market estimates and forecast, 2018 - 2030
Fig. 26 Others (semisolid, semiliquid) market estimates and forecast, 2018 - 2030
Fig. 27 Asia Pacific medical foods market: Application model analysis
Fig. 28 Asia Pacific medical foods market: Application model outlook and key takeaways
Fig. 29 Chronic kidney disease market estimates and forecast, 2018 - 2030
Fig. 30 Minimal hepatic encephalopathy market estimates and forecast, 2018 - 2030
Fig. 31 Chemotherapy induced diarrhea market estimates and forecast, 2018 - 2030
Fig. 32 Pathogen related infections market estimates and forecast, 2018 - 2030
Fig. 33 Diabetic neuropathy market estimates and forecast, 2018 - 2030
Fig. 34 ADHD market estimates and forecast, 2018 - 2030
Fig. 35 Depression market estimates and forecast, 2018 - 2030
Fig. 36 Alzheimer's disease market estimates and forecast, 2018 - 2030
Fig. 37 Nutritional deficiency market estimates and forecast, 2018 - 2030
Fig. 38 Orphan diseases market estimates and forecast, 2018 - 2030
Fig. 39 Tyrosinemia market estimates and forecast, 2018 - 2030
Fig. 40 Eosinophilic Esophagitis market estimates and forecast, 2018 - 2030
Fig. 41 Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES)) market estimates and forecast, 2018 - 2030
Fig. 42 Phenylketonuria (PKU) market estimates and forecast, 2018 - 2030
Fig. 43 Maple syrup urine disease (Maple syrup urine disease (MSUD)) market estimates and forecast, 2018 - 2030
Fig. 44 Homocystinuria market estimates and forecast, 2018 - 2030
Fig. 45 Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) market estimates and forecast, 2018 - 2030
Fig. 46 Wound healing market estimates and forecast, 2018 - 2030
Fig. 47 Chronic diarrhea market estimates and forecast, 2018 - 2030
Fig. 48 Constipation relief market estimates and forecast, 2018 - 2030
Fig. 49 Protein booster market estimates and forecast, 2018 - 2030
Fig. 50 Dysphagia market estimates and forecast, 2018 - 2030
Fig. 51 Pain management market estimates and forecast, 2018 - 2030
Fig. 52 Parkinson's disease market estimates and forecast, 2018 - 2030
Fig. 53 Epilepsy market estimates and forecast, 2018 - 2030
Fig. 54 Other cancer related treatments market estimates and forecast, 2018 - 2030
Fig. 55 Severe protein allergy market estimates and forecast, 2018 - 2030
Fig. 56 Cancer market estimates and forecast, 2018 - 2030
Fig. 57 Chacexia market estimates and forecast, 2018 - 2030
Fig. 58 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2018 - 2030
Fig. 59 Asia Pacific medical foods market: Module model analysis
Fig. 60 Asia Pacific medical foods market: Module model outlook and key takeaways
Fig. 61 Amino acid module market estimates and forecast, 2018 - 2030
Fig. 62 Protein module market estimates and forecast, 2018 - 2030
Fig. 63 Vitamin & mineral modules market estimates and forecast, 2018 - 2030
Fig. 64 Fatty acid based modules market estimates and forecast, 2018 - 2030
Fig. 65 Carbohydrate modules market estimates and forecast, 2018 - 2030
Fig. 66 Fiber modules market estimates and forecast, 2018 - 2030
Fig. 67 Ketogenic modules market estimates and forecast, 2018 - 2030
Fig. 68 Peptide based modules market estimates and forecast, 2018 - 2030
Fig. 69 Hypoallergic modules market estimates and forecast, 2018 - 2030
Fig. 70 Others (electrolyte module, etc.) market estimates and forecast, 2018 - 2030
Fig. 71 Asia Pacific medical foods market: Sales channel model analysis
Fig. 72 Asia Pacific medical foods market: Sales channel model outlook and key takeaways
Fig. 73 DTC sales channel market estimates and forecast, 2018 - 2030
Fig. 74 Online sales market estimates and forecast, 2018 - 2030
Fig. 75 Retail sales market estimates and forecast, 2018 - 2030
Fig. 76 Institutional sales market estimates and forecast, 2018 - 2030
Fig. 77 Hospitals market estimates and forecast, 2018 - 2030
Fig. 78 Others (long-term care facilities, etc.) market estimates and forecast, 2018 - 2030
Fig. 79 Asia Pacific medical foods market: Country movement analysis
Fig. 80 Asia Pacific medical foods market: Country outlook and key takeaways
Fig. 81 Asia Pacific medical foods market share and leading players
Fig. 82 Asia Pacific SWOT
Fig. 83 Asia Pacific
Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 85 China
Fig. 86 China market estimates and forecasts, 2018 - 2030
Fig. 87 Japan
Fig. 88 Japan market estimates and forecasts, 2018 - 2030
Fig. 89 Australia
Fig. 90 Australia market estimates and forecasts, 2018 - 2030
Fig. 91 India
Fig. 92 India market estimates and forecasts, 2018 - 2030
Fig. 93 South Korea
Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
Fig. 95 Thailand
Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
Fig. 97 Vietnam
Fig. 98 Vietnam market estimates and forecasts, 2018 - 2030
Fig. 99 Market share of key market players- Asia Pacific medical foods market

Companies Mentioned

  • Mead Johnson & Company, LLC
  • SHS International ltd
  • Synutra International ltd
  • Milupa Gmbh
  • Danone
  • Nestlé
  • Abbott
  • Fresenius Kabi AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.94 Billion
Compound Annual Growth Rate6.2%
Regions CoveredAsia Pacific
No. of Companies Mentioned8

Related Topics

Related Reports

Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product (Powder, Pills, Liquid, Other), Application, Sales Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product (Powder, Pills, Liquid, Other), Application, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Medical Food Market by Route of Administration, Form, Formulation, Age Group, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Medical Food Market by Route of Administration, Form, Formulation, Age Group, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Medical Foods Market Report by Product, Route of Administration, Application, Distribution Channel, and Region 2024-2032 - Product Image

Medical Foods Market Report by Product, Route of Administration, Application, Distribution Channel, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Medical Foods - Global Strategic Business Report - Product Image

Medical Foods - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Medical Foods for Orphan Diseases Global Market Report 2024 - Product Image

Medical Foods for Orphan Diseases Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Market

Medical food is a type of healthcare service that provides specialized nutrition for the dietary management of a medical condition. It is intended to be used under medical supervision and is regulated by the U.S. Food and Drug Administration (FDA). Medical food is designed to provide specific nutrients that may not be available in a regular diet, and is often used to treat conditions such as diabetes, kidney disease, and liver disease. It is also used to supplement the diets of those with malabsorption syndromes, food allergies, and other conditions. Medical food is typically available in a variety of forms, including powders, liquids, bars, and capsules. It is often used in combination with other treatments, such as medications, to help manage a medical condition. Some companies in the medical food market include Abbott Nutrition, Nestle Health Science, Danone Nutricia, and Mead Johnson Nutrition. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.